- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04141943
Improvement of Patient Experience and Healthcare Providers' Productivity Using Virtual Reality in the Field of Radiation Therapy
Study Overview
Detailed Description
All patients enrolled in this study will receive the same routine explanation all radiotherapy patients receive currently. However, prior to the routine explanation, additional detailed information regarding radiotherapy (from simulation to treatment) will be given in two different ways.
VR arm: The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality.
Printed document arm: The patients who are allocated to the Printed document arm will receive information about radiotherapy via printed document.
Patients will answer the questionnaire related to the anxiety scale related to radiotherapy and measure the vital signs such as blood pressure, pulse rate, and the respiratory rate. Also, patients will answer the questions about radiotherapy to assess the understanding of radiotherapy and questionnaire on hospital satisfaction.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Korea
-
Seoul, Korea, Korea, Republic of, 120-752
- Recruiting
- Severance Hospital
-
Contact:
- YongBae Kim, MD
- Phone Number: 82-10-6256-2592
- Email: ybkim3@yuhs.ac
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Breast cancer patients who received curative surgery and are planned to receive radiotherapy
- Patients with cognitive abilities to receive virtual reality information
- Patients who are 20 years old or older
Exclusion Criteria:
- Patients who have vision or hearing problems to receive information
- Patients who do not agree to this study
- Pregnancy, Fetuses / Newborns, Minors, and Deficient Patients
- 65 years old or older
- Patients who have been treated for dizziness within the last 6 months
- Patients who have experienced severe dizziness within the last 6 months when using electronic devices
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VR
The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality
|
The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality.
|
|
No Intervention: Printed document
The patients who are allocated to the Printed document arm will receive information about radiotherapy via printed document.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Time Frame: Prior to receiving the radiotherapy information via VR or printed document
|
Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information - APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious) |
Prior to receiving the radiotherapy information via VR or printed document
|
|
Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Time Frame: 5 minutes after receiving the radiotherapy information via VR or printed document
|
Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information - APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious) |
5 minutes after receiving the radiotherapy information via VR or printed document
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State-Trait Anxiety Inventory (STAI)
Time Frame: Prior to receiving the radiotherapy information via VR or printed document
|
Changes in STAI Before and After Providing Virtual Reality or Printed Document Information
|
Prior to receiving the radiotherapy information via VR or printed document
|
|
State-Trait Anxiety Inventory (STAI)
Time Frame: 5 minutes after receiving the radiotherapy information via VR or printed document
|
Changes in STAI Before and After Providing Virtual Reality or Printed Document Information
|
5 minutes after receiving the radiotherapy information via VR or printed document
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2019-0795
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.